Jefferies analyst Chris Howerton reiterated a Buy rating and $183.00 price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) ahead of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE